Hanson McClain Advisors »

Atea Pharmaceuticals shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $183 63 2.90

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)
2023 Etf Series Trust Ii Gmo Us Quality E (QLTY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Usd Inv Grde Etf (USIG)
Nvidia Corporation Call Call Option (Principal) (NVDA)

View all positions for Hanson McClain Advisors

Top funds holding Atea Pharmaceuticals

BlackRock
BML Capital Management
FMR
Tang Capital Management
Vanguard Group
Bain Capital Life Sciences Investors
Geode Capital Management
State Street Corporation
Dimensional Fund Advisors
Renaissance Technologies
Acadian Asset Management
Two Sigma Advisers
Northern Trust
Charles Schwab Investment Management
Jpmorgan Chase & Co

View all funds holding Atea Pharmaceuticals